Tag Archive | "epithelial growth factory receptor"
Presence of rash associated with improved survival in patients receiving adjuvant Erbitux® for locally advanced head and neck cancer
Source: professional.cancerconsultants.com Author: staff A multicenter randomized trial has shown that patients with locoregionally advanced head and neck cancer receiving adjuvant Erbitux® (cetuximab) and radiotherapy who develop a rash have a better survival than patients receiving this therapy who don’t develop a rash. The details of this five-year follow-up of a Phase III randomized study [...]
Continue reading...- Accuracy of Dentists in the Clinical Diagnosis of Oral Lesions
- New Evaluation for HPV16 Related Cancers Using "Pap-Test Equivalent"
- New Study Indicates Tobacco Industry Was Aware of Their Own Products Dangers
- Increase in oral cancers linked to HPV
- Systems Strategies To Support Cancer Screening in U.S. Primary Care Practice
- Study Finds- Fewer Dying from Throat & Mouth Cancer in the U.S.
- UI professors: HPV editorial misses the mark
- Girls-Only Vaccine Could Be Best Weapon Against HPV
- Many Head and Neck Cancer Survivors Face Eating Problems
- The Gardasil Problem: How The U.S. Lost Faith In A Promising Vaccine
- hilllaguna: This reply originally posted on the Knight Science...
- Brian Hill: I wonder who paid for this bit of research to be d...
- Brian Hill: Maybe in the Netherlands this mathematical model f...
- Brian Hill: The foundation would like to commend the doctors w...
- Brian Hill: While these doctors have looked at an overview of ...
- Keith Hern – Battling throat cancer, chemotherapy, radiotherapy and NLP
- Vitamin B veggies cut risk of mouth cancer
- Oral sex may cause more oral cancer than smoking in men, researchers say
- Big Tobacco Spending More Than a Super PAC to Defeat Cancer Research
- Actor’s Diagnosis Puts Spotlight on Oral Cancer
- Actor Michael Douglas Partners With Oral Cancer Foundation For Early Detection PSA Campaign
- 2009 Federal Tobacco Tax Increase Cut Number of Youth Smokers by At Least 220,000 in First Two Months Alone, New Study Shows
- Radiotherapy May Be Enough for HPV-Positive Throat Cancer
- Stem cell sparing radiotherapy for head and neck cancer may avoid salivary gland damage
- 1 of 6 cancer deaths worldwide caused by preventable infections
alcohol
cancer
CDC
Cervarix
cervical cancer
cetuximab
chemotherapy
chewing tobacco
cigarettes
cisplatin
DNA
early detection
FDA
Food and Drug Administration
Gardasil
genital warts
head and neck cancer
HPV
HPV-16
human papillomavirus
human papilloma virus
lung cancer
mouth cancer
National Cancer Institute
nicotine
oral cancer
oral cancer foundation
oral sex
oropharyngeal cancer
radiation
radiation therapy
radiotherapy
screening
smokeless tobacco
smoking
snus
squamous cell carcinoma
surgery
survival
The Oral Cancer Foundation
throat cancer
tobacco
vaccination
vaccine
xerostomia
Follow OCF on these social networking sites connect to us, get involved, spread the knowledge, help the cause, change the world.
Tuesday, November 17, 2009
0 Comments